These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11683593)

  • 1. Adipose tissue concentrations of dioxins and dibenzofurans, titers of antibodies to Epstein-Barr virus early antigen and the risk for non-Hodgkin lymphoma.
    Hardell L; Lindström G; van Bavel B; Hardell K; Linde A; Carlberg M; Liljegren G
    Environ Res; 2001 Oct; 87(2):99-107. PubMed ID: 11683593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated antibody levels to Epstein-Bbarr virus antigens in patients with hairy cell leukemia compared to controls in relation to exposure to pesticides, organic solvents, animals, and exhausts.
    Nordström M; Hardell L; Linde A; Schloss L; Näsman A
    Oncol Res; 1999; 11(11-12):539-44. PubMed ID: 10905566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-control study on concentrations of organohalogen compounds and titers of antibodies to Epstein-Barr virus antigens in the etiology of non-Hodgkin lymphoma.
    Hardell E; Eriksson M; Lindström G; Van Bavel B; Linde A; Carlberg M; Liljegren G
    Leuk Lymphoma; 2001 Aug; 42(4):619-29. PubMed ID: 11697490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does smoking or alcohol modify the risk of Epstein-Barr virus-positive or -negative Hodgkin lymphoma?
    Willett EV; O'Connor S; Smith AG; Roman E
    Epidemiology; 2007 Jan; 18(1):130-6. PubMed ID: 17099321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of non-Hodgkin lymphoma and serum organochlorine concentrations among neighbors of a municipal solid waste incinerator.
    Viel JF; Floret N; Deconinck E; Focant JF; De Pauw E; Cahn JY
    Environ Int; 2011 Feb; 37(2):449-53. PubMed ID: 21167603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus in biopsies from patients with Hodgkin and non-Hodgkin lymphoma at the University of Puerto Rico immunohistochemistry laboratory.
    Córdova Pérez FJ; González-Keelan CI; Vélez R
    P R Health Sci J; 2003 Jun; 22(2):125-9. PubMed ID: 12866135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study.
    Hjalgrim H; Ekström-Smedby K; Rostgaard K; Amini RM; Molin D; Hamilton-Dutoit S; Schöllkopf C; Chang ET; Ralfkiaer E; Adami HO; Glimelius B; Melbye M
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1561-6. PubMed ID: 17684129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring.
    Tedeschi R; Bloigu A; Ogmundsdottir HM; Marus A; Dillner J; dePaoli P; Gudnadottir M; Koskela P; Pukkala E; Lehtinen T; Lehtinen M
    Am J Epidemiol; 2007 Jan; 165(2):134-7. PubMed ID: 17005627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
    Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dioxin emissions from a solid waste incinerator and risk of non-Hodgkin lymphoma.
    Floret N; Mauny F; Challier B; Arveux P; Cahn JY; Viel JF
    Epidemiology; 2003 Jul; 14(4):392-8. PubMed ID: 12843761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of organohalogen compounds and titres of antibodies to Epstein-Barr virus antigens and the risk for non-Hodgkin lymphoma.
    Hardell K; Carlberg M; Hardell L; Björnfoth H; Ericson Jogsten I; Eriksson M; Van Bavel B; Lindström G
    Oncol Rep; 2009 Jun; 21(6):1567-76. PubMed ID: 19424638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma.
    Chang ET; Zheng T; Lennette ET; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
    J Infect Dis; 2004 Jun; 189(12):2271-81. PubMed ID: 15181575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies.
    Teras LR; Rollison DE; Pawlita M; Michel A; Brozy J; de Sanjose S; Blase JL; Gapstur SM
    Int J Cancer; 2015 Jan; 136(1):108-16. PubMed ID: 24831943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
    Feng YF; Wu QL; Zong YS
    Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of past infection with simian virus 40 (SV40) and risk of incident non-Hodgkin lymphoma in a Maryland cohort.
    Rollison DE; Helzlsouer KJ; Halsey NA; Shah KV; Viscidi RP
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1448-52. PubMed ID: 15941954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
    Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
    Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.